# |
PMID |
Sentence |
1 |
17149545
|
We then examined insulin signaling pathway where palmitate significantly inhibited insulin stimulated phosphorylation of Insulin receptor tyrosine kinase, IRS 1and PI3 kinase, PDK1 and Akt/PKB.
|
2 |
17149545
|
LPA(4) rescued this inhibition of signaling molecule by palmitate.
|
3 |
17149545
|
Insulin mediated translocation of Glut4, the glucose transporter in insulin target cells, was effectively blocked by palmitate while, LPA(4) waived this block.
|
4 |
17149545
|
Administration of LPA(4) to nutritionally induced diabetic rats significantly reduced the increase in plasma glucose.
|
5 |
17149545
|
All these indicate LPA(4) to be a potentially therapeutic agent for insulin resistance and type 2 diabetes.
|
6 |
17149545
|
We then examined insulin signaling pathway where palmitate significantly inhibited insulin stimulated phosphorylation of Insulin receptor tyrosine kinase, IRS 1and PI3 kinase, PDK1 and Akt/PKB.
|
7 |
17149545
|
LPA(4) rescued this inhibition of signaling molecule by palmitate.
|
8 |
17149545
|
Insulin mediated translocation of Glut4, the glucose transporter in insulin target cells, was effectively blocked by palmitate while, LPA(4) waived this block.
|
9 |
17149545
|
Administration of LPA(4) to nutritionally induced diabetic rats significantly reduced the increase in plasma glucose.
|
10 |
17149545
|
All these indicate LPA(4) to be a potentially therapeutic agent for insulin resistance and type 2 diabetes.
|
11 |
17149545
|
We then examined insulin signaling pathway where palmitate significantly inhibited insulin stimulated phosphorylation of Insulin receptor tyrosine kinase, IRS 1and PI3 kinase, PDK1 and Akt/PKB.
|
12 |
17149545
|
LPA(4) rescued this inhibition of signaling molecule by palmitate.
|
13 |
17149545
|
Insulin mediated translocation of Glut4, the glucose transporter in insulin target cells, was effectively blocked by palmitate while, LPA(4) waived this block.
|
14 |
17149545
|
Administration of LPA(4) to nutritionally induced diabetic rats significantly reduced the increase in plasma glucose.
|
15 |
17149545
|
All these indicate LPA(4) to be a potentially therapeutic agent for insulin resistance and type 2 diabetes.
|